Trial record 2 of 4 for:
Eosinophilic Esophagitis | Ellodi [Lead]
24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05634746 |
Recruitment Status :
Active, not recruiting
First Posted : December 2, 2022
Last Update Posted : May 6, 2024
|
Sponsor:
Ellodi Pharmaceuticals, LP
Information provided by (Responsible Party):
Ellodi Pharmaceuticals, LP
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | September 2024 |
Estimated Study Completion Date : | March 2025 |